Shares of OptiBiotix Health Plc (LON:OPTI – Get Rating) reached a new 52-week low during trading on Friday . The stock traded as low as GBX 11.75 ($0.14) and last traded at GBX 12 ($0.14), with a volume of 130935 shares traded. The stock had previously closed at GBX 12.25 ($0.15).
OptiBiotix Health Stock Performance
The stock has a market cap of £11.17 million, a P/E ratio of 204.17 and a beta of 1.61. The company has a quick ratio of 7.89, a current ratio of 8.39 and a debt-to-equity ratio of 4.51. The firm’s 50-day moving average is GBX 13.48 and its two-hundred day moving average is GBX 15.92.
About OptiBiotix Health
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
Recommended Stories
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
